Endothelium-derived nitric oxide and vascular physiology and pathology

Cellular and Molecular Life Sciences

Volumn 55, Issue 8-9, 1999, Pages 1078-1087

  Arnal, J F ^a   Dinh Xuan, A T ^b   Pueyo, M ^c   Darblade, B ^a   Rami, J ^a  

^a CHU RANGUEIL   (France)

^b CHU Cochin Port Royal ^*  (France)

^c BICHAT HOSPITAL   (France)

Author keywords

Atherosclerosis; Endothelium; Hypertension; Nitric oxide; Nitric oxide synthase

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ARGININE; BRADYKININ; CITRULLINE; ENDOTHELIUM DERIVED RELAXING FACTOR; FREE RADICAL; HISTAMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SEROTONIN; THROMBIN; VASODILATOR AGENT;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ATHEROMA; ATHEROSCLEROSIS; CALCIUM CELL LEVEL; CELL PROLIFERATION; CYTOSKELETON; CYTOSOL; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTIMA; INTRACELLULAR TRANSPORT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SHEAR STRESS; SMOKING; SMOOTH MUSCLE RELAXATION; THROMBOCYTE FUNCTION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0032777665     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050358     Document Type: Review

References (85)

1. 1 Furchgott R. F. and Zawadzki J. V. (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 228: 373-376
2. 2 Ignarro L. J. (1989) Endothelium-derived nitric oxide: actions and properties. FASEB J. 3: 31-36
3. 3 Moncada S. and Higgs A. (1993) The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012
4. 4 Cohen R. and Vanhoutte P. (1995) Endothelium-dependent hyperpolarisation: beyond nitric oxide and cyclic GMP. Circulation 92: 3337-3349
5. 5 Ross R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809
6. 6 Griffith O. W. and Stuehr D. J. (1995) Nitric oxide synthases: properties and catalytic mechanism. Ann. Rev. Physiol. 57: 707-736
7. 7 Nathan C. (1997) Inducible nitric oxide synthase: what difference does it make? J. Clin. Invest. 100: 2417-2423
8. 8 Michel T. and Feron O. (1997) Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. 100: 2146-2152
9. 9 Nishida K., Harrison D. G., Navas J. P., Fisher A. A., Dockery S. P., Uematsu M. et al. (1992) Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J. Clin. Invest. 90: 2092-2096
10. 10 Sessa W. C., Pritchard K., Seyedi N., Wang J. and Hintze T. H. (1994) Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74: 349-353
11. 11 Arnal J. F., Clamens S., Pechet C., Nègre-Salvayre A., Allera C., Girolami J. P. et al. (1996) Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine aortic endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc. Natl. Acad. Sci. USA 93: 4108-4113
12. 12 Kleinert H., Wallerath T., Euchenhofer C., Ihrig-Biedert I., Li H. and Förstermann U. (1998) Estrogens increase transcription of human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31: 582-588
13. 13 Arnal J.-F., Yamin J., Dockery S. and Harrison, D. G. (1994) Regulation of endothelial nitric oxide synthase mRNA, protein and activity during cell growth. Am. J. Physiol. 267: C1381-C1388
14. 14 Yoshizumi M., Perrella M. A., Burnett J. C. and Lee M.-E. (1993) Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73: 205-209
15. 15 Okamoto T., Schlegel A., Scherer P. and Lisanti M. (1998) Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane. J. Biol. Chem. 273: 5419-5422
16. 16 McDonald K., Zharikov S., Block E. and Kilberg M. (1997) A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric oxide synthase may explain the 'arginine paradox'. J. Biol. Chem. 272: 31213-31216
17. 17 Michel T., Li G. K. and Busconi L. (1993) Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. USA 90: 6252-6256
18. 18 Corson M., James N., Latta S., Nemrem R., Berk B. and Harrison D. (1996) Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ. Res. 79: 984-991
19. + +/ calmodulin and caveolin. J. Biol. Chem. 272: 15583-15586
20. 20 Ayajiki K., Kindermann M., Hecker M., Fleming I. and Busse R. (1996) Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ. Res. 78: 750-758
21. 21 Ludmer P. L., Selwyn A. P., Shook T. L., Wayne R. R., Mudge G. H., Alexander R. W. et al. (1986) Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315; 1046-1051
22. 22 Pueyo M., Arnal J. F., Rami J. and Michel J. B. (1998) Angiotensin II-stimulated NO and peroxynitrite production in endothelial cells. Am. J. Physiol. 274: C214-C220
23. 23 Lüscher R., Boulanger C., Yang Z., Noll G. and Dohi Y. (1993) Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 87 (Suppl. 5): V36-V44
24. 24 Moncada S. and Higgs E. A. (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21: 361-374
25. 25 Radomski M. W., Palmer R. M. and Moncada S. (1991) Modulation of platelet aggregation by an L-arginine-nitric oxide pathway. Trends Pharmacol. Sci. 12: 87-88
26. 26 Arnal J. F., Warin L. and Michel J. B. (1992) Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J. Clin. Invest. 90: 647-652
27. 27 Luvara G., Pueyo M., Philippe M., Mandet C., Savoie F., Henrion D. et al. (1998) Chronic blockade of NO synthase activity induces a proinflammatory phenotype in the arterial wall: prevention by angiotensin II antagonism. Arterioscler. Thromb. Vasc. Biol. 18: 1408-1416
28. 28 Baylis C., Mitruka B. and Deng A. (1992) Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 90; 278-281
29. 29 Blot S., Arnal J. F., Wu Y., Gray F. and Michel J. B. (1994) Spinal cord infarets during long-term inhibition of nitric oxide synthase in rats. Stroke 25: 1666-1673
30. 30 Chatziantoniou C., Boffa J., Ardaillou R. and Dussaule J. (1998) Nitric oxide inhibition induces early activation of type 1 collagen gene in renal resistance vessels and glomeruli in transgenic mice. J. Clin. Invest. 101: 2780-2789
31. 31 Yamazaki J., Fujita N. and Nagao T. (1991) NG-Monomethyl-L-arginine-induced pressor response at developmental and established stages in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 259: 52-57
32. 32 Arnal J. F., Battle T., Menard J. and Michel J. B. (1993) The vasodilatory effect of endogenous nitric oxide is a major counter-regulatory mechanism in the spontaneously hypertensive rat. J. Hypertens. 11: 945-950
33. 33 Chen P. Y. and Sanders P. W. (1991) L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 88: 1559-1567
34. 34 Chen P. Y., St-John P. L., Kirk K. A., Abrahamson D. R. and Sanders P. W. (1993) Hypertensive nephrosclerosis in the Dahl/Rapp rat: initial sites of injury and effect of dietary L-arginine supplementation. Lab. Invest. 68: 174-184
35. 35 Panza J. A., Casino P. R., Badar D. M. and Quyyumi A. A. (1993) Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 87: 1475-1481
36. 36 Panza J. A., Casino P. R., Kilcoyne C. M. and Quyyumi A. A. (1993) Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87: 1468-1474
37. 37 Treasure C. B., Manoukian S. V., Klein J. L., Vita J. A., Nabel G. N., Renwick G. H. et al. (1992) Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res. 71: 776-681
38. 38 Verbeuren T. J., Jordaens F. H., Zonnekeyn L. L., Van Hove C. E., Coene M. C. and Herman A. G. (1986) Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ. Res. 58: 552-564
39. 39 Cayatte A. J., Palacino J. J., Horten K. and Cohen R. A. (1994) Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb. 14: 753-759
40. 40 Elhage R., Bayard F., Richard V., Holvoet P., Duverger N., Fiévet C. et al. (1997) The prevention of fatty streak formation of 17β-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice. Circulation 96: 3048-3052
41. 41 Harrison D. (1997) Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 100: 2153-2157
42. 42 Pollock J. S., Forstermann U., Mitchell J. A., Warner T. D., Schmidt H. H., Nakane M. et al. (1991) Purification and characterization of participate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88: 10480-10484
43. 43 Hecker M., Sessa W. C., Harris H. J., Anggard E. E. and Vane J. R. (1990) The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. USA 87: 8612-8616
44. 44 Cooke J., Singer A., Tsao P., Zera P., Rowan R. and Billigham M. (1992) Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90: 1168-1172
45. 45 Cooke J. P. (1994) Is NO an endogenous antiatherogenic molecule? Arterioscler. Thromb. 14: 653-655
46. 46 Forstermann U., Closs E. I., Pollock J. S., Nakane M., Schwaz P., Gath I. et al. (1994) Nitric oxide synthase isozymes: characterisation, purification, molecular cloning, and functions. Hypertension 23: 1121-1131
47. 47 Arnal J. F., Munzel T., Venema R. C., James N. L., Bay C. L., Mitch W. et al. (1995) Interactions between L-arginine and L-glutamine modulate endothelial NO production: an effect independent of NO synthase substrate availability. J. Clin. Invest. 95: 2565-2572
48. 48 Harrison D. G., Venema R. C., Arnal J. F., Inoue N. Ohara Y., Sayegh H. et al. (1995) The endothelial cell nitric oxide synthase: is it really constitutively expressed? In: Mediators in the cardiovascular system: regional ischemia, pp. 107-117, Birkhäuser, Basel
49. 49 Wilcox J., Subramanian R., Sundell C., Tracey W. R., Pollock J. S., Harrison D. G. et al. (1997) Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. Arterioscler. Thromb. Vasc. Biol. 17: 2479-2488
50. 50 Shimokawa H., Flavahan N. A. and Vanhoutte P. M. (1991) Loss of endothelial pertussis toxin sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation 83: 652-660
51. 51 Keaney J. F. J., Gaziano J. M., Xu Z., Frei B., Curran-Celentano J., Shwaery G. T. et al. (1994) Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J. Clin. Invest. 93: 844-851
52. 52 Meurice T., Bauters C., Vallet B., Corseaux D., Van Belle F., Human M. et al. (1997) bFGF restores endotheliumn-dependent responses of hypercholesterolemic rabbit thoracic aorta. Am. J. Physiol. 272: H613-H617
53. 53 Kessler P., Bauersachs J., Busse R. and Schini-Kerth V. (1997) Inhibition of inducible NO synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. Arterioscler. Thromb. Vasc. Biol. 17: 1746-1755
54. 54 De-Meyer G. R., Bult H., Van-Hoydonek A. E., Jordaens F. H., Buyssens N. and Herman A. G. (1991) Neointima formation impairs endothelial muscarinic receptors while enhancing prostacyclin-mediated responses in the rabbit carotid artery. Circ. Res. 68: 1669-1680
55. 55 Boulanger C. and Vanhoutte P. (1997) G proteins and endothelium-dependent relaxations. J. Vasc. Res. 34: 175-185
56. 56 Rubbo H., Darley-Usmar V. and Freeman B. (1996) Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9: 809-820
57. 57 Rosen G. M. and Freeman B. A. (1984) Detection of superoxide generated by endothelial cells. Proc. Natl. Acad. Sci. USA 81: 7269-7273
58. 58 Mohazzab-H K., Kaminski P. and Wolin M. (1994) NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 266: H2568-H2572
59. 59 Beckman J. S. and Koppenol W. H. (1996) Nitric oxide, superoxide, and peroxynitrate: the good, the bad, and the ugly. Am. J. Physiol. 271: C1424-C1437
60. 60 White C. R., Brock T. A., Chang L. Y., Crapo J., Briscoe P., Ku D. et al. (1994) Superoxide and peroxynitrite in atherosclerosis. Proc. Natl. Acad. Sci. USA 91: 1044-1048
61. 61 Mügge A., Elwell J. H., Peterson T. E., Hofmeyer T. G., Heistad D. D. and Harrison D. G. (1991) Chronic treatment with polyethylene glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ. Res. 69: 1293-1300
62. 62 Rajagopalan S., Meng X. P., Ramasamy S., Harrison D. G. and Galis Z. S. (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J. Clin. Invest. 98: 2572-2579
63. 63 Griendling K. and Alexander R. W. (1996) Endothelium control of the cardiovascular system: recent advances. FASEB J. 10: 283-292
64. 64 Rajagopalan S., Kurz S., Münzel T., Tarpey M. M., Freeman B. A., Griendling K. K. et al. (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J. Clin. Invest. 97: 1916-1923
65. 65 Xia Y., Tsai A., Berka V. and Zweier J. (1998) Superoxide generation from endothelial nitric oxide symhase. J. Biol. Chem. 273: 25804-25808
66. 66 Dinh-Xuan A. T. (1992) Endothelial modulation of pulmonary vascular tone. Eur. Respir. J. 5: 757-762
67. 67 Cremona G., Higenbottam T. W., Dinh-Xuan A. T., Wells F. C., Large S. R., Stewart S. et al. (1991) Inhibitors of endothelium-derived relaxing factor increase pulmonary vascular resistance in isolated perfused human lungs (abstract). Eur. Respir. J. (Suppl 14) 4: 336s
68. 68 Stamler J. S., Loh E., Roddy M. A., Currie K. E. and Creager M. A. (1994) Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89: 2035-2040
69. 69 Celermajer D. S., Dollery C., Burch M. and Deanfield J. E. (1994) Role of endothelium in the maintenance of low pulmonary vascular tone in normal children. Circulation 89: 2041-2044
70. 70 Brashers V. L., Peach M. J. and Rose C. E. Jr. (1988) Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J. Clin. Invest. 82: 1495-1502
71. 71 Mazmanian G. M., Baudet B., Brink C., Cerrina J., Kirkiacharian S. and Weiss M. (1989) Methylene blue potentiates vascular reactivity in isolated rat lungs. J. Appl. Physiol. 66: 1040-1045
72. 72 Archer S. L., Tolins J. P., Raij L. and Weir E. K. (1989) Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium-derived relaxing factor. Biochem. Biophys. Res. Commun. 164: 1198-1205
73. 73 Persson M. G., Gustafsson L. E., Wiklund N. P., Moncada S. and Hedqvist P. (1990) Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol. Scand. 140: 449-457
74. 74 Robertson B. E., Warren J. B. and Nye P. C. G. (1990) Inhibition of nitric oxide synthesis potentiates hypoxic vasoconstriction in isolated rat lungs. Exp. Physiol. 75: 255-257
75. 75 Liu S. F., Crawley D. E., Barnes P. J. and Evans T. W. (1991) Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am. Rev. Respir. Dis. 143: 32-37
76. 76 Crawley D. E., Liu S. F., Evans T. W. and Barnes P. J. (1990) Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries. Br. J. Pharmacol. 101: 166-170
77. 77 Yamaguchi T., Rodman D. M., O'Brien R. F. and McMurtry I. F. (1989) Modulation of pulmonary artery contraction by endothelium-derived relaxing factor. Eur. J. Pharmacol. 161: 259-262
78. 78 Dinh-Xuan A. T. (1993) Disorders of endothelium-dependent relaxation in pulmonary disease. Circulation (Suppl. 5) 87: V81-V87
79. 79 Rodman D. M., Yamaguchi T., Hasunuma K., O'Brien R. F. and McMurtry I. F. (1990) Effects of hypoxia on endothelium-dependent relaxation of rat pulmonary artery. Am. J. Physiol. 258: L207-L214
80. 80 Warren J. B., Maltby N. H., McCormack D. and Barnes P. J. (1989) Pulmonary endothelium-derived relaxing factor is impaired in hypoxia. Clin. Sci. 77: 671-676
81. 81 Dinh-Xuan A. T., Higenbottam T. W., Pepke-Zaba J., Clelland C. A. and Wallwork J. (1989) Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries. Fur. J. Pharmacol. 163: 401-403
82. 82 Dinh-Xuan A. T., Higenbottam T. W., Clelland C. A., Pepke-Zaba J., Cremona G., Butt A. Y. et al. (1991) Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 314: 1539-1547
83. 83 Dinh-Xuan A. T., Higenbottam T. W. and Wallwork J. (1992) Relationship between chronic hypoxia and in vitro pulmonary relaxation mediated by endothelium-derived relaxing factors in human chronic obstructive lung disease. Angiology 43: 9-10
84. 84 Dinh-Xuan A. T., Pepke-Zaba J., Butt A. Y., Cremona G. and Higenbottam T. W. (1993) Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to L-arginine deficiency. Br. J. Pharmacol. 109: 587-591
85. 85 Huang P., Huang Z., Mashimo H., Bloch K., Moskowitz M., Bevan J. et al. (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377: 239-242